To the delight of Wyoming’s top elected officials, President Donald Trump signed a series of executive orders Tuesday to ...

The FDA cleared the firm this week to begin a Phase I study of ALX2004 in EGFR-expressing solid tumors, which could start in a few months.

The former Facebook employee behind a scathing book about parent company Meta will testify Wednesday before US senators keen ...

Unions representing miners, nurses and other workers said the cuts will slow identification and prevention of workplace ...

The FDA cleared the investigational new drug application for ALX2004, with phase 1 trials expected to begin in mid-2025 for ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created ...

U.S. Health Secretary Robert F. Kennedy Jr. has traveled to the epicenter of Texas' measles outbreak after a second ...

Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer ...

Led by a team of distinguished toxicology experts, TriApex was thrilled to take part in this prestigious meeting, engaging in insightful discussions and building meaningful connections with industry ...

An excessive intake of zinc can lead to zinc toxicity. This toxicity can cause gastrointestinal discomfort and, when chronic, may also disrupt the balance of other chemicals in the body ...